Clinical trial

GP Extended Action Triptorelin

NCT01673984

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2012-08-01

PhasePHASE4

Study timeline

Study start (unknown)2012-08-01Date precision: month

Registry last updated2025-05-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

Decapeptyl® SR 22.5mgDRUG

Decapeptyl® SR 11.25mg; Prostap® 3 DCS 11.25mg; Zoladex® LA 10.8mgDRUG

Sponsors & collaborators

Ipsenlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01673984 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.